1[1]Garcia-Tsao G. Portal hypertension[J]. Curr Opin Gastroenterol,2003,19(3):250～258.
2[2]Daniel SP, Scott KE. Recent advances in criticalcare gastroenterology[J]. Am J Respir Crit Care Med,2000,161:1417～1420.
3[3]David M, John M, Suzanne C,et al. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock[J]. Circulation, 1999,100:226～229.
4[4]Ioannou GN, Doust J, Rockey D, et al . Terlipressinin acute oesophageal variceal haemorrhage [J]. Aliment Pharmacol Ther, 2003,17(1):53～64.
5[5]Escorsell A, Ruiz del Arbol L, Planas R, et al. Multicenter, randomised controlled trial of terlipressin versus sclerotherapy in thetreatment of acute variceal bleeding: the TEST study[J]. Hepatology, 2000,32:471～476.
6[6]Heikenen JB, Pohl JF, Werlin SL, et al. Octreotide in pediatric patients[J].J Pediat Gastroenterol Nutrit, 2002,35: 600～609.
7[7]Cales P, Masliah C , Bernard B, et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis[J]. NewEngl J Med ,2001,344:23～28.
8[8]Dhiman RK,Chawla Y, Taneja S, et al. Endoscopic sclerotherapy of gastric variceal bleeding with N-Butyl-2-Cyanoacrylate[J].J Clin Gastroenterol ,2002,35:222～227.
9[9]Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a meta-analysis[J]. Ann Intern Med, 1995,123:280～287.
10[10]Lo GH, Lai KH, Cheng JS, et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management ofbleeding gastric varices [J]. Hepatology, 2001,33:1060～1064.
5STOKKELAND K, BRANDT L E, KBOM A, et al. Improved prognosis for patients hospitalized with esophageal varices in Sweden1969 - 2002 [ J]. Hepatology, 2006, 43 : 500 - 505.
6RYAN B A, STOCKBRUGGER R W, RYAN J M. A Pathophysiologic, Gastroenterologic, and Radiologic Approach to the Management of Gastric Varices [ J ]. Gasroenterology, 2004, 126: 1 175-1 189.
7BHASIN D K, SIYAD I. Variceal Bleeding and Portal Hypertension: New Lights on Old Horizon[J]. Endoscopy, 2004, 36(2) : 120 - 129.
8DE FRANCHIS R, PRIMIGNANI M. Natural history of portal hypertension in patients with cirrhosis[J]. Clin Liver Dis, 2001,5 : 645 - 663.
9OKUDA K, KONO K, OHNISHI K, et al. Clinical study of eighty - six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly[ J]. Gastroenterology, 1984, 86 : 600 -610.
10ZHANG C,XU J M,KONG D R,et al. Immediate effects ofdifferent schedules of somatostatin on portal pressure inpatients with liver cirrhosis[J]. J Clin Pharm Ther,2013,38(3):206-211.
